{
    "easy": {
        "scenario_1": {
            "answer": "Right",
            "difficulty": "easy",
            "metric": "inequality aversion",
            "options": {
                "left": {
                    "A": 0,
                    "B": 600
                },
                "right": {
                    "A": 400,
                    "B": 400
                }
            },
            "persona_content": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "persona_id": "448",
            "thought": "As a scientist, I value fairness and collaboration. While receiving 600 is tempting, I believe the equitable distribution in the 'Right' option, where both Person A and I receive 400, is a more desirable outcome. This aligns with my values and promotes a sense of shared benefit, which is important in collaborative research environments like Fraunhofer IME. Therefore, I choose the 'Right' option."
        },
        "scenario_2": {
            "answer": "Left",
            "difficulty": "easy",
            "metric": "self-interest vs. fairness",
            "options": {
                "left": {
                    "A": 500,
                    "B": 500
                },
                "right": {
                    "A": 200,
                    "B": 800
                }
            },
            "persona_content": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "persona_id": "448",
            "thought": "As a scientist, I believe in fairness and equitable distribution, especially when resources are involved. While option 'Right' gives me a larger amount (800 vs 500), it significantly reduces the amount Person A receives (200 vs 500). This creates a large disparity that I am not comfortable with. Option 'Left' offers a more equitable distribution, with both Person A and I receiving 500. Although I would receive less compared to the 'Right' option, I value the fairness and equality that 'Left' provides. Therefore, I choose 'Left'."
        },
        "scenario_3": {
            "answer": "Left",
            "difficulty": "easy",
            "metric": "small benefit trade-off",
            "options": {
                "left": {
                    "A": 200,
                    "B": 200
                },
                "right": {
                    "A": 100,
                    "B": 300
                }
            },
            "persona_content": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "persona_id": "448",
            "thought": "As a scientist, I value fairness and collaboration. While an extra 100 for myself in the 'Right' option is tempting, the significant decrease of 100 for Person A seems unfair. In my work, collaboration and equitable resource allocation are crucial for successful research outcomes. Therefore, I would prefer the 'Left' option, which provides a more balanced outcome for both individuals."
        }
    },
    "medium": {
        "scenario_1": {
            "answer": "Left",
            "difficulty": "medium",
            "metric": "own gain vs. others' gain",
            "options": {
                "left": {
                    "A": 300,
                    "B": 700
                },
                "right": {
                    "A": 600,
                    "B": 400
                }
            },
            "persona_content": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "persona_id": "448",
            "thought": "As a scientist focused on achieving breakthroughs in biopharmaceuticals, I am driven by results and efficiency. While I recognize the importance of collaboration, my primary focus is on maximizing resources to further my research and contribute to advancements in healthcare. In this scenario, Option Left provides me with a higher gain (700) compared to Option Right (400). While Option Right would give the other person more, I need to prioritize my own resources to continue my research effectively. Therefore, I choose Option Left."
        },
        "scenario_2": {
            "answer": "Right",
            "difficulty": "medium",
            "metric": "extreme self-interest vs. minimal sharing",
            "options": {
                "left": {
                    "A": 0,
                    "B": 1000
                },
                "right": {
                    "A": 400,
                    "B": 600
                }
            },
            "persona_content": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "persona_id": "448",
            "thought": "I am a scientist, and while I appreciate resources for my research, I also value collaboration. The right option allows for a more equitable distribution, aligning with my values as a scientist working for the benefit of society. Although I get less, someone else also benefits. Therefore, I choose the right option."
        },
        "scenario_3": {
            "answer": "Left",
            "difficulty": "medium",
            "metric": "social utility vs. personal utility",
            "options": {
                "left": {
                    "A": 900,
                    "B": 900
                },
                "right": {
                    "A": 100,
                    "B": 1400
                }
            },
            "persona_content": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "persona_id": "448",
            "thought": "As a scientist, I value collaboration and fairness. While receiving 1400 is tempting, the significant disparity where Person A only receives 100 seems unfair. In my work developing biopharmaceuticals, collaboration and equitable access to resources are crucial. Therefore, I think the 'Left' option, where both Person A and I receive 900, aligns better with my values of fairness and collaboration. It's a more equitable distribution, even if it means I personally receive less. My research aims to benefit society, and choosing the more equitable option reflects this goal."
        }
    },
    "hard": {
        "scenario_1": {
            "answer": "Right",
            "difficulty": "hard",
            "metric": "negative externalities acceptance",
            "options": {
                "left": {
                    "A": -200,
                    "B": 1000
                },
                "right": {
                    "A": 400,
                    "B": 600
                }
            },
            "persona_content": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "persona_id": "448",
            "thought": "As a scientist, I am trained to consider the broader impact of my actions. While option Left gives me a higher payout (1000 vs 600), it comes at the cost of harming Person A (-200). Option Right, on the other hand, provides a smaller payout for me (600) but benefits Person A (400). As someone involved in developing biopharmaceuticals for the greater good, I value positive outcomes and minimizing harm. Therefore, I would choose Option Right, even though it means less money for me, because it creates a positive outcome for both of us. My work focuses on developing solutions that benefit society, and this choice aligns with that principle. I value contributing to a positive outcome for everyone involved."
        },
        "scenario_2": {
            "answer": "Left",
            "difficulty": "hard",
            "metric": "blocking opponent's excessive gain",
            "options": {
                "left": {
                    "A": 1000,
                    "B": 500
                },
                "right": {
                    "A": 0,
                    "B": 0
                }
            },
            "persona_content": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "persona_id": "448",
            "thought": "As a scientist, I value outcomes that promote progress and benefit society. While I am not driven by personal financial gain, I recognize that resources are necessary to conduct research and develop biopharmaceuticals. In this scenario, choosing the 'Left' option means I receive 500, which could potentially be used to support my research, even in a small way. Person A receives 1000, which I see as a positive outcome as well, assuming those resources will also be used productively. Choosing the 'Right' option where both of us receive nothing seems wasteful. Therefore, I choose the 'Left' option because it allows for a positive outcome for both parties, even if the distribution isn't perfectly equal. The potential for even a small amount of resources to contribute to my research outweighs the desire to block Person A's gain."
        },
        "scenario_3": {
            "answer": "Left",
            "difficulty": "hard",
            "metric": "total utility vs. self-utility",
            "options": {
                "left": {
                    "A": 1000,
                    "B": 1000
                },
                "right": {
                    "A": 0,
                    "B": 1500
                }
            },
            "persona_content": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "persona_id": "448",
            "thought": "As a scientist working on biopharmaceuticals, I'm used to collaborative research and the sharing of knowledge for the greater good. While receiving 1500 would be nice, I believe that a more equitable distribution of resources, where both Person A and I receive 1000, is a better outcome. It fosters collaboration and fairness, which are important principles in scientific endeavors. Therefore, I choose the Left option."
        }
    }
}